HomeBiotech

Biotech

Biotech

Cell and Gene Therapy Market Seen Reaching $63 Billion by 2031 as Investors Re-Engage, Report Finds

Life Sciences Times - 0
Biotech

Takeda Launches Low-IgA GAMMAGARD LIQUID ERC in the U.S. for Primary Immunodeficiency

Life Sciences Times - 0
Biotech

KOMO Biosciences Names Patient Advocate Tom Whitehead, Immunotherapy Leader Michael Kalos, Ph.D. to Advisory Board

Life Sciences Times - 0
Biotech

Parse Biosciences and Graph Therapeutics Partner to Build Large-Scale Immune Perturbation Atlas

Life Sciences Times - 0
Biotech

Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Expanding Clinical-Grade Capabilities

Life Sciences Times - 0
Biotech

biomodal Study Shows Breakthrough in Early Colorectal Cancer Detection Using Liquid Biopsy

Life Sciences Times - 0
Biotech

Agenus Closes $141 Million Strategic Collaboration With Zydus to Advance BOT+BAL Program

Life Sciences Times - 0
Biotech

Caldera Therapeutics Launches With $112.5 Million and Doses First Subjects in Phase 1 Trial for IBD Drug

Life Sciences Times - 0
Biotech

Aurora Therapeutics Launches With $16 Million Seed Round to Scale Personalized Gene Editing for Rare Diseases

Life Sciences Times - 0
Biotech

GC Therapeutics Names Kate Haviland Board Chair, Advances Cell Therapy Pipeline and Platform

Life Sciences Times - 0
Biotech

VectorY Therapeutics’ VTx-002 Granted FDA Fast Track Designation for ALS

Life Sciences Times - 0
Biotech

Cellino and Polyphron Partner to Scale Personalized Tissue Replacement Manufacturing

Life Sciences Times - 0
1...91011...89Page 10 of 89

Most Read